| Trustees' Annual Report for the period | |||||||
| **From ** | Period start date | To | Period end date | ||||
| 01 | 01 | 2025 | 18 | 12 | 2025 |
Section A Reference and administration details
ASSOCIATION OF BIOMEDICAL ENGINEERS, MEDICAL Charity name ENGINEERS, AND BIOENGINEERS Other names charity is known by BioMedEng Association Registered charity number (if any) 1191005 Charity's principal address Department of Bioengineering, Imperial College London, Bessemer Building, London Postcode SW7 2AZ
Names of the charity trustees who manage the charity
| 1 2 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
Trustee name | Office (if any) | Dates acted if not for whole year |
Name of person (or body) entitled to appoint trustee (if any) |
|---|---|---|---|---|
| Prof Alicia El Haj | Universityof Birmingham | |||
| Prof AnthonyBull | Imperial College London | |||
| Prof Hazel Screen | Queen MaryUniversityof London | |||
| Prof Vanessa Diaz | UniversityCollege London | |||
Names of the trustees for the charity, if any, (for example, any custodian trustees) Name Dates acted if not for whole year
March 2012
TAR
1
Names and addresses of advisers (Optional information)
| Names and addresses of advisers (Optional information) | Names and addresses of advisers (Optional information) | Names and addresses of advisers (Optional information) |
|---|---|---|
| Type of adviser Name Address |
||
| Name of chief executive or names of senior staff members | ||
| Dr Gifty Tetteh – Head of Operations |
Section B Structure, governance and management
Description of the charity’s trusts
Charitable Incorporated Organisation Constitution Type of governing document (eg. trust deed, constitution) Association Model Constitution How the charity is constituted (eg. trust, association, company) Charity trustees are appointed by a resolution of the members at the Trustee selection methods annual general meeting. (eg. appointed by, elected by) Co-opted Trustees can also be appointed at any time by current trustees.
- (eg. trust, association, company)
Additional governance issues (Optional information)
The BioMedEng Association Trustees’ Board for the 2025 reporting period You may choose to include comprised of the four Trustees (Profs Alicia El Haj, Anthony Bull, Hazel additional information, where Screen and Vanessa Diaz). They were supported by the current Chair of relevant, about: Council (Prof Martin Knight). The Head of Operations (Dr Gifty Tetteh) • policies and procedures stepped down from this role during the year.
- policies and procedures adopted for the induction and training of trustees;
Similar to the 2024 report, the Trustees’ Board is supported by the formal members of the Association, including the Chairs of the Working Groups (Education, Equality, Diversity and Inclusion, Early Career Researchers, Industry and Sponsorship, and Communications and Website) and the BioMedEng Council.
- the charity’s organisational structure and any wider network with which the charity works;
In addition to the formal members, the Association has established a wider affiliate membership provision. As detailed in our previous reports, the affiliate memberships are open to practising engineers, clinicians, students, and anyone who is interested in Biomedical Engineering, Medical Engineering and Bioengineering.
-
relationship with any related parties;
-
trustees’ consideration of major risks and the system and procedures to manage them.
We welcome applications from UK members from Industry, Academic Institutions and Research Centres, Clinical Establishments and Hospitals, Governmental and Non-Governmental Organisations, amongst others.
March 2012
TAR
2
Section C Objectives and activities
Summary of the objects of the charity set out in its governing document
Our charitable objects remain unchanged. The BioMedEng Association aims to advance education for the public benefit in biomedical engineering, medical engineering, and bioengineering, in particular but not exclusively by:
- organising and holding scientific meetings and conferences; 2. and promoting the study and practice of biomedical engineering, medical engineering and bioengineering.
The Association is a professional body for engineers, clinicians, researchers, and students working within Biomedical Engineering, Medical Engineering and Bioengineering disciplines.
Activities cover our annual conference and working group activities to promote biomedical engineering, medical engineering, and bioengineering, as outlined below:
BioMedEng25 Conference
The Universities of Strathclyde and Glasgow ran the 2025 conference. Together with the Trustees and Council members of the Association of Biomedical Engineers, Medical Engineers and Bioengineers, they welcomed delegates to the Technology and Innovation Centre, at the University of Strathclyde, for BioMedEng25 on the 4[th] and 5[th] of September 2025.
The local organising committee consisted of
-
Dr Helen Mulavana, University of Glasgow, Co-chair
-
Dr Philip Riches, University of Strathclyde, Co-chair
-
Dr Marie-Claire Parker, University of Strathclyde
Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)
-
Prof Arjan Buis, University of Strathclyde
-
Dr Asimina Kazakidi, University of Strathclyde
-
Dr Ankush Aggarwahl, University of Glasgow
-
Dr Carsten Schulte, University of Strathclyde
-
Dr Cristina Gonzalez Garcia, University of Glasgow
Special mention must be made to Sarah Eastham and Lorna Merret, who ran the social media campaign, a large band of student volunteers who welcomed and helped delegates throughout the conference, the Students’ Union for hosting our social event and the University of Strathclyde Conference Management Services, without whom the conference would have not been so successful or enjoyable.
The conference was opened by Baillie Hanif Raja MBE from Glasgow City Council and Professor Stephen McArthur, Principal of the University of Strathclyde.
There were two plenary speakers for BioMedEng25 : • Professor Praminda Caleb-Solly, University off Nottingham, and • Professor Keith Mathieson, University of Strathclyde.
In addition to our Plenary speakers, we had four keynote speakers in the scientific programme. Our keynote speakers were: • Prof. Jonathan Cooper, University of Glasgow • Prof Maiwenn Kersaudy-Kerhoas, Heriot-Watt University • Prof. Will Shu, University of Strathclyde • Prof. Adriana Tavares, University of Edinburgh
Four workshops were distributed about the programme with, notably, ANSYS and Thermofisher putting on free workshops for conference
March 2012
TAR
3
delegates. An ECR workshop focussed on the challenges facing early career researchers and a Digital Health and Co-creation Workshop were also held. An App was created with all the required information for delegates to fully engage with the conference.
The conference received sponsorship for a range of industry partners:
The programme consisted of 26 oral sessions, split across four parallel sessions, in the areas of biomechanics, cardiovascular mechanics, tissue engineering, engineering innovations, prosthetics and orthotics, women’s health, AI-driven insights, biomedical imaging, biosensing, clinical and surgical engineering, rehabilitation, emerging tools, interfaces and systems, and inclusive design. In total, there were 148 oral presentations and 91 posters. In total 349 delegates attended the conference.
On 4[th] September, 173 conference delegates dined and danced the night away in traditional Scottish style with a Ceilidh in the Students’ Union.
BioMedEng25 awarded best poster and best oral presentation prizes, which were voted for by the delegates throughout the conference. Further, we also gave a prize for the research which best incorporated principles of inclusive design.
On the Friday afternoon we invited over one hundred 16 to 18 year’ old school children studying maths and physics, from across Scotland to engage in the conference viewing the Posters, see exhibiting companies and having biomedical engineering technology demonstration tables.
March 2012
TAR
4
The conference team have met with the trustees to finalise the accounts and gather feedback and constructive suggestions for future conferences, whilst arranging for funds to be transferred in line with the proceeds split arrangements, alongside providing valuable support for the organisers of BioMedEng26
More information about the BioMedEng25 conference is available at BioMedEng25: The BioMedEng Association
Additional activity from our working groups:
March 2012
TAR
5
Early Career Bioengineers (ECB) Working Group : During 2025, the Early Career Bioengineers (ECB) Working Group (formerly the Early Career Researchers Working Group) continued to meet regular every 2 months to support the development and engagement of early-career professionals across the bioengineering community. The Group delivered a successful workshop on the use of artificial intelligence in academic and research practice at the BioMedEng 2025 Conference, attracting 40 participants and receiving highly positive feedback. Workshop materials were subsequently collated for wider dissemination through the new BioMedEng Association website/Intranet. The Group also strengthened its communications through the launch of an ECB Bluesky account, contributed to the development of content for the Association’s new website, and began planning future conference, outreach and entrepreneurship activities. The mentoring network remained a central activity, with existing systems reviewed and updated mentor-mentee resources prepared. The Group also welcomed two new members, supporting its continued growth and development. Chair: Silvia Del-Din
Education Working Group : The education working group met on three occasions in 2025. They have created three outreach packs which have been sent out to secondary schools, they have been piloted in a select number of schools and feedback has been used to make improvements and roll out more widely. Chair: Anita Ghag
Industry Working Group: The industry working group met twice in 2025, and supported the local organiser with two industry sponsors whom continued to support our annual meetings in previous years (i.e. ANSYS and Thermo Fisher). Together with one of our industry partners (ANSYS) the group ran our 2[nd] BioMedEng in conversation with industry event on 26[th] June 2025. This event was in person, at University College London, and brought together representative from 8 companies, 5 universities and 2 regulatory bodies. Chair: Mehran Moazen
EDI Working Group : This working group membership is drawn from volunteers within the Bio Med Eng community and includes senior members that are also on Council as well as early career members new to committee work. In particular, we have in mind to represent the host cities of our recent conference venues, different regions of the country and under-represented groups. The aims of the EDI working group are to
-
Understand barriers to inclusion within our BioMedEng society and related engineering fields.
-
Increase visibility, representation and progression of underrepresented groups in the BioMedEng community (collaboration with ECR team).
• Support Biomedical Engineering research that is more inclusive in terms of both the end users needs and contributors to the design The EDI working group met online 4 times and had one hybrid meeting in 2025. The main focus for the EDI working group in 2025 was to encourage more abstracts with an ‘inclusive engineering’ element. For this purpose we instigated a new prize ‘BioMedEng association prize for inclusive engineering [year]’. 2025 was a pilot run of the prize and was used to create an annual procedure. The prize is based on abstract submission not final presentation as the aim is to encourage people working on inclusive design/engineering in their research to submit abstracts and attend BioMedEng. During the abstract submission process delegates were asked to tick a box if they wished to be considered for the prize. 34 abstracts were submitted. These were
March 2012
TAR
6
screened by the committee and ranked based on how well the researchers had considered and included one of more under-represented groups. Screening was anonymous with no names or institute affiliation included. The preliminary ranking led to a shortlisted group which were selected for the ‘inclusive design’ session. Some shortlisted abstracts had already been selected for other sessions and the decision was to keep them there to have inclusive engineering spread throughout the conference sessions. The top 10 ranked abstracts were then graded by the working group to select a final winner. The winning paper was by Lois Galletly entitled ‘Design requirements for above-knee adjustable socket design.
Chair: Gwendoline Riley
Additional details of objectives and activities (Optional information)
You may choose to include further statements, where relevant, about:
-
policy on grantmaking;
-
policy programme related investment;
-
contribution made by volunteers.
March 2012
TAR
7
Section D Achievements and performance
Summary of the main achievements of the charity during the year
5[th] BioMedEng AGM – The 2025 AGM of the BioMedEng Association took place at the BioMedEng25 Conference on 6[th] September 2025 at Strathclyde. This covered both operational updates on the Association and presentations from the Chair of Council and the Working Group Chairs on activities during the year.
Like previous years, the AGMs provided an opportunity for both formal and affiliate BioMedEng members to review activities of the Association, propose initiatives, and discuss important updates about the charity .
The AGM was chaired by Prof Martin Knight (Chair of Council) with the working group chairs providing an update on activities as outlined above.
Prof Hazel Screen provided an operational update, focused on the Charity Objects, Committee Changes, Membership Updates, Finance and Sustainability. As previously mentioned, the Association’s charitable objects remain unchanged.
Similar to last year’s arrangement, the Association held a separate Council meeting prior to the 5[th] AGM, to review the years activities and discuss key strategic Association initiatives prior to the 5[th] AGM.
Elections: The Chair reminded members that there will be no Trustee elections in this AGM. The board asked the Chair of Council Prof Martin Knight to extend his term for a further 2 years. As in previous years, the BioMedEng conference chairs – Prof Yalin Zheng and Dr Riaz Akhtar were invited to join council. Conference Planning: There was an open call for universities to bid to run BioMedEng, with Council selecting University of Leicester (Dr Jenny Shepherd) to run BioMedEng27 and Imperial College London (Dr Joseph van Batenburg-Sherwood) to run BioMedEng28.
Membership – The Association membership rates remained unchanged. The membership rates for the 2024 reporting year were £50/year for Full members, £20/year* for Research Student Members (PhD, MPhil and MRes), £75 for 5 years for Retired/Emeritus Members, and free annual memberships to verified undergraduate and MSc students.
As detailed in our previous reports, the Association’s membership is open to practising engineers, clinicians, students, and anyone who is interested in Biomedical Engineering, Medical Engineering and Bioengineering. We welcome applications from UK and International members from Industry, Academic Institutions and Research Centres, Clinical Establishments and Hospitals, Governmental and NonGovernmental Organisations, amongst others.
Finance and Sustainability: Prof Hazel Screen discussed the details of the 2024 Independently Examined Accounts at the 5[th] AGM. This showed an income and expenditure of £21,830.73 and £81,819.37, respectively.
The high expenditure for the 2024 reporting period relative to the income resulted from the delayed payments of the QMUL conference expenses at £62,101.66. Other expenditure reduced relative to previous years as the Association did not have to with pay a contribution to support the operations manager’s salary, as they were on maternity leave.
The previous end of year accounts reported £135,468.23, inflated owing to the liability to conference hosts QMUL.
March 2012
TAR
8
Section D Achievements and performance
With the QMUL conference making a profit of £47,289.17 and generously donating 75% to the Association (£35,466.88), the overall Association balance for 2024 having paid all liabilities was £75,479.59.
March 2012
TAR
9
Section E Financial review
| Brief statement of the charity’s policy on reserves Details of any funds materially in deficit Further financial review details Youmay chooseto include additional information, where relevant about: • the charity’s principal sources of funds (including any fundraising); • how expenditure has supported the key objectives of the charity; • investment policy and objectives including any ethical investment policy adopted. |
The previous end of year accounts reported £135,468.23, inflated owing to the liability to conference hosts QMUL. The actual closing balances, after all liabilities had been paid for the 2021, 2022 and 2023 financial years were £11,952, £20,518.96, and £30,096.3, respectively. The QMUL conference making a profit of £47,289.17 and generously donating 75% to the Association (£35,466.88), the overall Association balance for 2024 having paid all liabilities was £75,479.59 The Trustees acknowledged the significant contribution from QMUL and thanked the Conference Co-Chairs and team, for their generous donation to the Association. Further income arose from membership fees with very little expenditure such that the closing balance for 2024 having paid all liabilities was £75,479.509. The 2024 accounts have been independently examined with a copy attached to this report. Please see the attached independently examined accounts for further details on the Association’s financial position. |
|---|---|
| No funds are in deficit | |
| (Optional information) | |
| As detailed in the independently examined 2025 accounts attached, the Association’s core income is generated from membership dues and proceeds from hosting dedicated events and the annual conference. |
Section F Other optional information
March 2012
TAR
10
Section G Declaration
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
Signature(s) Full name(s) Prof Hazel Screen Position (eg Secretary, Chair, Trustee and Treasurer etc) Date 28.09.2026
March 2012
TAR
11
ASSOCIATK)N OF 810MEDICAL ENGINEERS. EDICAL ENGINEERS AND BK)ENGINEERS 1191005 FINANCIAL ACCOUPW6 FOR THE YEAR ENDED 31 DECEM Legal and Administratrie Inde[ent ExaThMner rei*xt Reipts and Payments Atcounts Statement of Assets and LIalitIeS
ASSOCIATION OF Bk)MEDICAL ENGINEER& AIEDICAL ENGINEERS AMD WEt4GINEERS 1191005 ORGANISATIONAL PROFILE FOR THE YEAR ENDED 31 DECEER TRUSTEES Prd Ak4a El Haj Prof AnthY Bull Prof Hatsi Sue REGISTERED OFFICE: The BioMedEng A$$"al)ft Department of &'oerVJinlng Imwal Cdle9e London Bessemer BuildThJ London UK SWT 2AZ ACcOUNTMs. Chats Osei. Bsc (Horts), MSC. FCIE. AFA, ATA. MCIPP FFal 3, 11 Way London SE8 4LY
CHARITY COMMISSION FOR ENGLAND AND WALES Independent examIneS report on the accounts Section A Independent Examiner's Report Roport to the truste members of ASSOCIATION OF BIOMEDICAL ENGINEERS. MEDICAL ENGINEERS AND BIOENGINEERS On accounts for the year ended 3111212025 Charity no (rf ally) 1191005 Set out on pages -1 sheelsl T:. InClb¢ Ir Vaae,.ty.s Ot adOilicn- I reFQrt to the trustees on rny examination of the accounts ofthe atx)ve charity llhe Twstl for the yw ended 31112 12025. Responsibililies and the charity trustees of the Trus( you are resp(sIble for the preparation basis of report of the aco)unts in accordartt with the Nuirements of the Chariti'es Act 20111tr Acr). I rert in respeca of my examination ofthe Trusys accounts carried out under SeCb 145 ofthe 2011 Act and in carying oui my examination, I have forlorf1 the applicable Directions given by the Charity Commission under Sect 145(5){b) of the Acl. I have comFleted my examination. I confirm that no material matters have me to my attention (other than thal disck)sed below ") in COnnectn wrth the examination vthith gives me cause to beIve that in, any material Independent examinerfs ststement )unting recx)rds were not kept in ac(xwdance with section 130 of the Act or the accounts do ncrt with the urIting rrdS I have no concems and have come rOsS no other matters in connectic wrth the examinalion to whth attention should be drawn in order to enable a proper understanding of the accounts to be reached. . eaSe delete the wonts in the brthts rfthey do not appty. 1410712026 Signed: Namo: Chartes Osei, Bsc (Hons), MSC. FCIE. AFA ATA. MCIPP Relevant professlonal quallfi¢ationlsl or body (If any): Assocothm of Charity 1ndeper¥jen Examiners Address: Flat 3, 11 Rhdale Way Deptford London SE8 4LY
Section B Disclosure on complete rf the examiner needs lo hwJhlight matters of concern (see CC32, Independent examinabon of charity accints." directions and gutdance for examiners). Give here brief detslls of any itgms that the oxaminer wishes to dlsclose.
ASSOCIATtON OF BIOMEDICAL ENGINEERS. MEDICAL ENGINEERS AND BIOENGINEERS Receipts and payments accounts 1191005 CC16a 01m11225 To 3111212025 Section A Receipts and payments Unrestricted RÈstricted Ettdo¥¥mÈnt L••iy¢•r Al Recei M8Tnbers' SubScp)nS Industy Event Conference Fee8 Sheffield Conferenox Fees Other 9.450 19.¢XX) 19,C0 100.615 21 A2 Ass¢t and 1N•s1 sal•s. {• tsblèl. 211 .831 110,055 Refunds Pro(ssin BioMedEn 24 W8hite Eyrw. ECR MarreP 1.820 92 101 101 1.520 83 Video Hosti BioM8dEng23 Costs Ch Swansea Uni BioMedEn 23 conferen Awards BioMedEng24 Costs and Charyes. QMUL 2023 Host Inshon Conlrbubo Imperial BioMedE 25 Inde ndenl Examinalb)n BioMedEn rial Award5 tional- Tra¥el rational- c0TrdonCas Stationa and Posti 62.102 62.102 19,OC 49) 19.C 23$ 162 Sub tolal 81.819 Bl,819 urcha table Sub totsi 81.819 81.819 64.201 N•tof rnc•lpWfpaymwits) A5 Transfers tetween funds A6 Cash funtts lasiyear end Cash funds thls year qnd 135, 75.479 75,479 135.468 2V09IXJ26
Section B Statement of assets and liabilities at the end of the period Unrestricted funds Restricted Endo¥vment nds to Norest£ iategones ton•rnt£ B1 Cash fund* 75.479 Tolal cash funds 76A79 Jnds Detalls DÈtalls ¢uwreThtV•lu• Detalls B4 Ass•ts rètsin8d forth• ¢harity's own use Detsils B5 Llabllltl¢8 &gn8d Wol al the Iru Date of roval Swjnaknre 2V09n026
Zi